Health Care [ 8/12 ] | Pharmaceuticals [ 14/73 ]
NASDAQ | Common Stock
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate.
It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil.
Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 12, 25 | -0.20 Decreased by -42.86% | -0.18 Decreased by -11.11% |
| May 12, 25 | -0.31 Decreased by -47.62% | -0.20 Decreased by -58.97% |
| Mar 19, 25 | -0.19 Increased by +40.63% | -0.15 Decreased by -26.67% |
| Nov 11, 24 | -0.14 Increased by +59.26% | -0.16 Increased by +10.87% |
| Aug 8, 24 | -0.14 Increased by +62.16% | -0.19 Increased by +26.32% |
| May 13, 24 | -0.21 Increased by +40.00% | -0.26 Increased by +19.23% |
| Mar 21, 24 | -0.32 Decreased by -3.23% | -0.31 Decreased by -3.23% |
| Nov 13, 23 | -0.35 Decreased by -2.94% | -0.38 Increased by +7.89% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -12.97 M Decreased by -38.48% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Increased by +100.00% | -20.76 M Decreased by -100.51% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 108.00 K Increased by +112.44% | -12.36 M Increased by +9.17% | Decreased by -11.45 K% Decreased by -830.01% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -9.44 M Increased by +37.41% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -9.36 M Increased by +41.64% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | -868.00 K Decreased by -186.80% | -10.35 M Increased by +30.74% | Increased by +1.19 K% Increased by +179.79% |
| Dec 31, 23 | -868.00 K Decreased by -124.80% | -13.61 M Decreased by -174.55% | Increased by +1.57 K% Increased by +200.60% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -15.08 M Decreased by -7.09% | Decreased by N/A% Decreased by N/A% |